Clinical Trials Browser

Phase 2 × Breast Neoplasm Female × pertuzumab × Clear all

NCT05969184 2023-08-01

Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

Phase 2 Unknown

Breast Neoplasm Female